In addition, the supraphysiological glucose concentrations commonly used in vitro, as well as those observed in diabetic mouse plasma, may not represent the glycemic profiles of most individuals with diabetes undergoing insulin therapy. The gene discussed is INS; the disease is diabetes mellitus.